A Boston federal magistrate judge is allowing plaintiffs’ experts to conduct “destructive” testing, including inspection of walls and ductwork, at New England Compounding Pharmacy Inc., a company linked to a fungal meningitis outbreak that caused 37 deaths.

In addition, the federal judge running the consolidated docket of District of Massachusetts cases for pretrial purposes, In Re New England Compounding Pharmacy Cases, has remanded two of the cases back to state court.